BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 692233)

  • 21. [Alternate day prednisone treatment in myasthenia].
    Mares A; Nisipeanu P; Lazăr T; Tudoran C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1974; 19(5):395-401. PubMed ID: 4549646
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Sanders DB; Aarli JA; Cutter GR; Jaretzki A; Kaminski HJ; Phillips LH
    Neurology; 2006 Mar; 66(6):954-5; author reply 954-5. PubMed ID: 16567729
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term results of corticosteroid therapy in patients with myasthenia gravis.
    Evoli A; Batocchi AP; Palmisani MT; Lo Monaco M; Tonali P
    Eur Neurol; 1992; 32(1):37-43. PubMed ID: 1563453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.
    Benatar M; Sanders DB; Wolfe GI; McDermott MP; Tawil R
    Ann N Y Acad Sci; 2012 Dec; 1275():17-22. PubMed ID: 23278573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioral dermatitis in a patient with myasthenia gravis following systemic corticosteroid treatment.
    Goss JM; Nord KM; Olarte MR; Grossman ME
    Br J Dermatol; 2007 Mar; 156(3):582. PubMed ID: 17300257
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immuno suppressive drugs in the treatment of myasthenia (author's transl)].
    Buscaino GA
    Riv Patol Nerv Ment; 1974 Aug; 95(4):399-410. PubMed ID: 4377801
    [No Abstract]   [Full Text] [Related]  

  • 28. Disseminated thymoma and myasthenia gravis: dramatic response to prednisone.
    Taylor R; Tandan R; Roberts J; DiCostanzo DP; Sharma K; Fries T
    Ann Neurol; 1989 Feb; 25(2):208-9. PubMed ID: 2919872
    [No Abstract]   [Full Text] [Related]  

  • 29. Cryptococcal cellulitis in a patient on prednisone monotherapy for myasthenia gravis.
    Lafleur L; Beaty S; Colome-Grimmer MI; LaForte RA; Dotson AD
    Cutis; 2004 Sep; 74(3):165-70. PubMed ID: 15499758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Corticosteroids in the treatment of myasthenia gravis. Study of 12 cases with review of the literature].
    Lamartine de Assis J
    Arq Neuropsiquiatr; 1975 Mar; 33(1):33-40. PubMed ID: 1164206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myasthenia gravis--treatment with prednisone].
    Spalek P; Lisý L
    Cesk Neurol Neurochir; 1982 Nov; 45(6):418-24. PubMed ID: 7151207
    [No Abstract]   [Full Text] [Related]  

  • 32. [Low-dosage prednisone in myasthenia gravis].
    Pugesgaard T
    Ugeskr Laeger; 1983 Apr; 145(16):1228-9. PubMed ID: 6879751
    [No Abstract]   [Full Text] [Related]  

  • 33. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
    Patzold U; Kalies I; Haas J; Ginda EM
    Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of antenatal myasthenia gravis.
    Carr SR; Gilchrist JM; Abuelo DN; Clark D
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):485-9. PubMed ID: 1870801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis: prolonged treatment with steroids.
    Sghirlanzoni A; Peluchetti D; Mantegazza R; Fiacchino F; Cornelio F
    Neurology; 1984 Feb; 34(2):170-4. PubMed ID: 6538004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous treatment of myasthenia gravis with prednisone.
    Dalby A; Kjaer M; de Fine Olivarius B
    Lancet; 1971 Mar; 1(7699):597-8. PubMed ID: 4100930
    [No Abstract]   [Full Text] [Related]  

  • 37. Myasthenia gravis.
    Murray KB
    Kans Med; 1990 Jun; 91(6):181-3. PubMed ID: 2398638
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of myasthenia gravis pseudoparalytica].
    Rüster M; Dietel K
    Kinderarztl Prax; 1970 Jul; 38(7):309-12. PubMed ID: 5523869
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical remission after corticosteroid therapy of acquired myasthenia in three dogs.
    Maddison JE; Waelchli-Suter CM; Johnson RP
    J Am Vet Med Assoc; 1984 Apr; 184(7):845-8. PubMed ID: 6725125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.